Signup/Login
If you want to receive notifications of upcoming IPOs, you need to simply sign up or sign in with social networks.
Signup/Login
Can you determine which companies are good and which ones - the trash?
Free Pro-version
IPO Filter
Monitor
IPO today
First Advantage Corporation (FA)
Sprinklr, Inc. (CXM)
Coliseum Acquisition (MITAU)
Upcoming IPO
Soulgate Inc. (SSR)
Bright Health Group Inc. (BHG)
Doximity, Inc. (DOCS)
Miromatrix Medical, Inc (MIRO)
Confluent, Inc. (CFLT)
Monte Rosa Therapeutics Inc. (GLUE)
Amtd Digital, Inc. (HKD)
Unicycive Therapeutics Inc. (UNCY)
Acurx Pharmaceuticals (ACXP)
Mister Car Wash, Inc. (MCW)
Elevation Oncology, Inc. (ELEV)
Alpha Teknova, Inc. (TKNO)
Gh Research Plc (GHRS)
Graphite Bio, Inc. (GRPH)
The Glimpse Group (VRAR)
Integral Ad Science Holding Corp. (IAS)
Clear Secure, Inc. (YOU)
D-MARKET Electronic Services & Trading (HEPS)
Missfresh Limited (MF)
Dingdong (cayman) Limited (DDL)
Xometry, Inc. (XMTR)
Sentinelone, Inc. (S)
Intapp, Inc. (INTA)
Cvrx, Inc. (CVRX)
Legalzoom.com, Inc. (LZ)
Torrid Holdings, Inc. (CURV)
Evercommerce Inc (EVCM)
Krispy Kreme, Inc. (DNUT)
Priced IPO
Full Truck Alliance Co. Ltd. (YMM)
Century Therapeutics, Inc (IPSC)
Atai Life Sciences B.v. (ATAI)
Femasys (FEMY)
Tremor International Ltd. (TRMR)
Cyteir Therapeutics, Inc. (CYT)
Codex Dna, Inc. (DNAY)
Aihuishou International Co. Ltd. (RERE)
Ambrx Biopharma Inc (AMAM)
iSpecimen (ISPC)
Angel Oak Mortgage, Inc. (AOMR)
Lyell Immunopharma, Inc. (LYEL)
Verve Therapeutics, Inc. (VERV)
Molecular Partners Inc. (MOLN)
Walkme Ltd. (WKME)
Convey Holding Parent, Inc. (CNVY)
Alzamend Neuro (ALZN)
Taskus, Inc. (TASK)
Janux Therapeutics, Inc. (JANX)
Kanzhun Limited (BZ)
More companies

Vaccitech Plc. (VACC)

Sector - Healthcare

Price chart

-4.18%
Return from IPO

Company News

IPO Profile

About company

Company Logo
They are a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer. They use their proprietary platform to develop product candidates that stimulate powerful, targeted immune responses against pathogens and tumor cells. They design their product candidates to stimulate immune responses that are robust, highly specific, and are differentiated by the magnitude of the T cell populations induced, which exhibit critical functionality and durability. They are focused on applying their platform capabilities and the expertise of their team to address significant unmet medical needs in two settings—the therapeutic setting, for the treatment of chronic infectious diseases and cancer, and the prophylactic setting, for the prevention of infectious diseases, based on their platform’s ability to respond rapidly to epidemic and pandemic threats.
Industry
Pharmaceutical Preparations
CEO CFO
William Enright Georgy Egorov
Employees Founded
48 2016

Contacts

Address: Vaccitech Plc The Schrödinger Building Heatley Road The Oxford Science Park Oxford Ox4 4ge United Kingdom

Telephone: +44 (0) 1865 818 808

Web page: http://www.vaccitech.co.uk

IPO information

First Trade Date 4/30/2021
Status Priced
Exchange NASDAQ
Lockup Period Expiration .Pro
Quiet Period Expiration .Pro
Old Price Range
-
Share prices ($)

Shares & Volumes

Shares Initial (MM) 6.5
Shares Revised (MM) 6.5
Expected offer amount (MM) $110.5
Realized offer amount(MM) $110.5

Financial Data (last reporting year)

Market Cap (MM) $579.02
Revenues (MM) $4.82
Net Income (Loss) (MM) $-17.93

Voting

What do you think will happen with the VACC share price after the next 3-6 months? 🔥 (+ 10% or more, flat (+ -10%), -10% or less)

Number of votes: img
The lead left underwriter: Morgan Stanley

IPOs led by the firm .Pro
Profitability of conducted IPOs  ?  .Pro
1st day change  ?  .Pro
Change for the first 3 months  ?  .Pro
Underwriters
Morgan Stanley/ Jefferies/ Barclays/ William Blair
CO-Managers
H.C. Wainwright

Sector: Healthcare

Tweets about $VACC

Tweets volume:

RT volume:

Timeframe:

Google Trends Stats